NEXT Financial Holdings’s Ionis Pharmaceuticals IONS Stock Holding History

NEXT Financial Holdings’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$21K	Buy	+264	New	+$17K	0.01%	954

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NEXT Financial Holdings's IONS Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2019: 264 shares worth $21K. The stake represents 0.01% of the portfolio and ranks #954 among its holdings.

392 funds tracked by Wall St. Rank hold IONS as of Q1 2019.

NEXT Financial Holdings held 264 shares of Ionis Pharmaceuticals worth $21K as of Q1 2019.
Ionis Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
Ionis Pharmaceuticals made up 0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #954 holding.
392 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.